Home/Altimmune/Cynthia Musante, Ph.D.

CM

Cynthia Musante, Ph.D.

Senior Vice President, Research & Development

Therapeutic Areas

Obesity Metabolic Dysfunction-Associated Steatohepatitis (MASH)Hypercholesterolemia

Altimmune Pipeline

Drug	Indication	Phase
Pemvidutide	Obesity	Phase 2
ALT-400	Undisclosed Metabolic Indication	Preclinical

Leadership Team at Altimmune

Vipin K. Garg, Ph.D.

President and Chief Executive Officer

Scott Harris, M.D.

Chief Medical Officer

Richard Eisenstadt

Chief Financial Officer

William Symonds, Pharm.D.

View full Altimmune profile